Global Alzheimer’s Initiative Now Act

HR 10175, the "Global Alzheimer’s Initiative Now Act," authorizes U.S. government participation and funding in the Davos Alzheimer’s Collaborative (DAC) to advance global efforts against Alzheimer’s disease and dementia. The bill requires U.S. contributions to be matched by non-U.S. funding, with U.S. spending capped at 33% of total DAC funds, and mandates annual reports to Congress detailing U.S. financial commitments and governance involvement. It directly affects U.S. agencies (State Department, USAID, HHS) and international health systems, particularly in low- and middle-income countries where over 70% of global cases occur. The legislation focuses on leveraging existing U.S. global health funding to support DAC’s work in developing diagnostics, treatments, and care strategies worldwide.